Issue navigation
Volume 14, Issue Supplement_2, June 1992
Articles
Evaluation of New Oral Antimicrobial Agents and the Experience with Cefprozil—A Broad-Spectrum Oral Cephalosporin
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Page S183, https://doi.org/10.1093/clinids/14.Supplement_2.S183
Pharmacology and Pharmacokinetics of Cefprozil
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S184–S188, https://doi.org/10.1093/clinids/14.Supplement_2.S184
Review of the In Vitro Antibacterial Activity of Cefprozil, A New Oral Cephalosporin
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S189–S194, https://doi.org/10.1093/clinids/14.Supplement_2.S189
Discussion: Barriere and Thornsberry
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S195–S196, https://doi.org/10.1093/clinids/14.Supplement_2.S195
Current Therapy for Otitis Media and Criteria for Evaluation of New Antimicrobial Agents
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S197–S203, https://doi.org/10.1093/clinids/14.Supplement_2.S197
Comparison of Cefprozil with Other Antibiotic Regimens in the Treatment of Children with Acute Otitis Media
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S204–S208, https://doi.org/10.1093/clinids/14.Supplement_2.S204
Discussion: Bluestone and Stutman
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S209–S211, https://doi.org/10.1093/clinids/14.Supplement_2.S209
Criteria for Evaluation of Antimicrobial Agents and Current Therapies for Acute Sinusitis in Children
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S212–S215, https://doi.org/10.1093/clinids/14.Supplement_2.S212
Extended Abstract: Cefprozil for Treatment of Acute and Uncomplicated Bacterial Sinusitis
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Page S216, https://doi.org/10.1093/clinids/14.Supplement_2.S216
Discussion: Giebink and van den Wijngaart
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Page S217, https://doi.org/10.1093/clinids/14.Supplement_2.S217
Streptococcal Pharyngitis: Current Therapy and Criteria for Evaluation of New Agents
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S218–S223, https://doi.org/10.1093/clinids/14.Supplement_2.S218
Treatment of Pharyngitis and Tonsillitis with Cefprozil: Review of Three Multicenter Trials
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S224–S230, https://doi.org/10.1093/clinids/14.Supplement_2.S224
Discussion: Peter and McCarty
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S231–S232, https://doi.org/10.1093/clinids/14.Supplement_2.S231
Antibacterial Therapy for Lower Respiratory Tract Infections in Adults: A Review
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S233–S237, https://doi.org/10.1093/clinids/14.Supplement_2.S233
Review of the Experience with Cefprozil for the Treatment of Lower Respiratory Tract Infections
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S238–S243, https://doi.org/10.1093/clinids/14.Supplement_2.S238
Discussion: La Force and Pelletier
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S244–S245, https://doi.org/10.1093/clinids/14.Supplement_2.S244
An Approach to Evaluating Antibacterial Agents in the Treatment of Urinary Tract Infection
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S246–S251, https://doi.org/10.1093/clinids/14.Supplement_2.S246
Extended Abstract: Multicenter Comparison of Safety and Efficacy of Cefprozil vs. Cefaclor in the Treatment of Acute and Uncomplicated Urinary Tract Infections
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Page S252, https://doi.org/10.1093/clinids/14.Supplement_2.S252
Discussion: Rubin and Iravani
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S253–S254, https://doi.org/10.1093/clinids/14.Supplement_2.S253
Clinical Trials of Cefprozil for Treatment of Skin and Skin-Structure Infections: Review
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S253–S263, https://doi.org/10.1093/clinids/14.Supplement_2.S255
Safety Profile of Cefprozil
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Pages S264–S271, https://doi.org/10.1093/clinids/14.Supplement_2.S264
Discussion: Nolen and Wilber
Clinical Infectious Diseases, Volume 14, Issue Supplement_2, June 1992, Page S272, https://doi.org/10.1093/clinids/14.Supplement_2.S272
